Your browser doesn't support javascript.
loading
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review.
Reininghaus, Eva Z; Manchia, Mirko; Dalkner, Nina; Bonkat, Nina; Squassina, Alessio; Hodl, Isabel; Vieta, Eduard; Reif, Andreas; Hajek, Tomas; Landén, Mikael; Correll, Christoph U; Scott, Jan; Etain, Bruno; Rietschel, Marcella; Bergink, Veerle; Martinez-Cengotitabengoa, Monica; Kessing, Lars Vedel; Fagiolini, Andrea; Bauer, Michael; Goodwin, Guy; Gonzalez-Pinto, Ana; Kupka, Ralph W; Schulze, Thomas G; Lagerberg, Trine V; Yildiz, Aysegül; Henry, Chantal; Morken, Gunnar; Ritter, Phillip; Nieslen, René Ernst; Licht, Rasmus W; Bechdolf, Andreas; Andreassen, Ole A; Fellendorf, Frederike Tabea.
Affiliation
  • Reininghaus EZ; Medical University Graz, Department of Psychiatry & Psychotherapeutic Medicine.
  • Manchia M; Unit of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari,Cagliari, Italy; Unit of Clinical Psychiatry, University Hospital Agency of Cagliari, Cagliari, Italy; Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.
  • Dalkner N; Medical University Graz, Department of Psychiatry & Psychotherapeutic Medicine.
  • Bonkat N; Medical University Graz, Department of Psychiatry & Psychotherapeutic Medicine.
  • Squassina A; Laboratory of Pharmacogenomics, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Hodl I; Medical University Graz, Klinische Abteilung für Rheumatologie und Immunologie.
  • Vieta E; Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Reif A; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy; University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Hajek T; Dalhousie University, Department of Psychiatry, Canada National Institute of Mental Health Klecany, Czech Republic; National Institute of Mental Health Klecany, Czech Republic.
  • Landén M; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Correll CU; Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Zucker Hillside Hospital, Department of Psychiatry, Northwel
  • Scott J; Institute of Neuroscience, Newcastle University, Newcastle, UK.
  • Etain B; Universite de Paris - INSERM UMRS 1144 - DMU Neurosciences, GHU Lariboisière Fernand Widal, Departement de Psychiatrie, APHP - Paris - France.
  • Rietschel M; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, University Heidelberg, Medical Faculty Mannheim, Mannheim, Germany.
  • Bergink V; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA; Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Martinez-Cengotitabengoa M; Osakidetza, Basque Health Service, Health Service, BioAraba Research Institute, University of the Basque Country, Vitoria, Spain; The Psychology Clinic of East Anglia, Norwich, England.
  • Kessing LV; Copenhagen Affective Disorder research Center (CADIC), Psychiatric Center Copenhagen, Copenhagen Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Fagiolini A; Universita di Siena, Molecular Medicine.
  • Bauer M; Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital Dresden, Technische Universität Dresden, Dresden, Germany.
  • Goodwin G; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Gonzalez-Pinto A; BIOARABA, Department of Neuroscience. UPV/EHU, CIBERSAM, Vitoria, Spain.
  • Kupka RW; Dept. of Psychiatry, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
  • Schulze TG; LMU University Hospital, Institute of Psychiatric Phenomics and Genomics (IPPG), Ludwig-Maximilians-University of Munich,Germany.
  • Lagerberg TV; NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Yildiz A; Dokuz Eylul University Izmir, Turkey Department of Psychiatry.
  • Henry C; Departement of Psychiatry, Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, Paris, France, Université de Paris, Paris, France.
  • Morken G; St Olav University Hospital and Norwegian University of Science and Technology - NTNU, Faculty of Medicine and Health Sciences.
  • Ritter P; Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital Dresden, Technische Universität Dresden, Dresden, Germany.
  • Nieslen RE; Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Licht RW; Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Bechdolf A; Department for Psychiatry, Psychotherapy and Psychosomatic, Vivantes Hospital am Urban and Friedrichshain; Charité Universitätsmedizin, Berlin, Germany.
  • Andreassen OA; NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; NORMENT Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Fellendorf FT; Medical University Graz, Department of Psychiatry & Psychotherapeutic Medicine.
Eur Neuropsychopharmacol ; 54: 90-99, 2022 01.
Article in En | MEDLINE | ID: mdl-34607722

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Vaccines / COVID-19 Type of study: Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Eur Neuropsychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Vaccines / COVID-19 Type of study: Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Eur Neuropsychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2022 Document type: Article